Form 8-K - Current report:
SEC Accession No. 0001213900-21-000823
Filing Date
2021-01-07
Accepted
2021-01-07 10:21:19
Documents
2
Period of Report
2021-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea132883-8k_immucell.htm 8-K 28129
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED JANUARY 7, 2021 ea132883ex99-1_immucell.htm EX-99.1 15379
  Complete submission text file 0001213900-21-000823.txt   44597
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 21513255
SIC: 2835 In Vitro & In Vivo Diagnostic Substances